Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP353471.RAH27KivR_Ak3dRB2y0oluhDX0x1xo-csrzqDR-lXP7tc130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP353471.RAH27KivR_Ak3dRB2y0oluhDX0x1xo-csrzqDR-lXP7tc130_assertion type Assertion NP353471.RAH27KivR_Ak3dRB2y0oluhDX0x1xo-csrzqDR-lXP7tc130_head.
- NP353471.RAH27KivR_Ak3dRB2y0oluhDX0x1xo-csrzqDR-lXP7tc130_assertion description "[An increase in the cellular levels of dihydrofolate reductase (DHFR) is one of the most common mechanisms of tumor resistance to methotrexate (MTX), an antimetabolite that is widely used in the treatment of a variety of human malignancies.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP353471.RAH27KivR_Ak3dRB2y0oluhDX0x1xo-csrzqDR-lXP7tc130_provenance.
- NP353471.RAH27KivR_Ak3dRB2y0oluhDX0x1xo-csrzqDR-lXP7tc130_assertion evidence source_evidence_literature NP353471.RAH27KivR_Ak3dRB2y0oluhDX0x1xo-csrzqDR-lXP7tc130_provenance.
- NP353471.RAH27KivR_Ak3dRB2y0oluhDX0x1xo-csrzqDR-lXP7tc130_assertion SIO_000772 10898545 NP353471.RAH27KivR_Ak3dRB2y0oluhDX0x1xo-csrzqDR-lXP7tc130_provenance.
- NP353471.RAH27KivR_Ak3dRB2y0oluhDX0x1xo-csrzqDR-lXP7tc130_assertion wasDerivedFrom befree-20150227 NP353471.RAH27KivR_Ak3dRB2y0oluhDX0x1xo-csrzqDR-lXP7tc130_provenance.
- NP353471.RAH27KivR_Ak3dRB2y0oluhDX0x1xo-csrzqDR-lXP7tc130_assertion wasGeneratedBy ECO_0000203 NP353471.RAH27KivR_Ak3dRB2y0oluhDX0x1xo-csrzqDR-lXP7tc130_provenance.